Rep. Gregory F. Murphy voted YEA on 100% of tracked bills classified as favoring Pharmaceuticals & Biotech and Real Estate sectors—his top donor sources—ranking #6 among House members on this metric. For example, he voted YEA on HR3537-117, the "Accelerating Access to Critical Therapies for ALS Act," classified as favoring the pharmaceutical sector, while voting YEA on 4 of 5 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
S723-119 — Tribal Trust Land Homeownership Act of 2025
FOLLOW THE TRAIL
◈ Ask the Analyst about Gregory F. Murphy →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated August 31, 2026 · internal signal score 88/100.